More than 100 different kinds of cancer, forming a constellation of illnesses of varying lethality and prevalence present research challenges.  Lacking a universal c ure for cancer, has led researchers to adopt new technologies, targeted to provide a productive path to selected new cancer treatments.    
 
No single intervention can cure all the different diseases.  Promising developments in the cure for cancer include precision oncology focused on the creation of tyrosine kinase inhibitors (TKIs) to target specific mutated cancers. 
 
These and other innovative initiatives are presented in the market research study.   The market research study provides insight into market driving forces, assessment of market opportunities, market share analysis, and market forecasts.